혜화의학회지 (Journal of Haehwa Medicine)

  • 제28권2호
  • /
  • Pages.54-59
  • /
  • 2019
  • /
  • 2586-3002(pISSN)
  • /
  • 2586-3347(eISSN)
대전대학교 한의학연구소 (Research Institute of Korean Medicine)
권호 표지

orafenib 복용 후 발생한 수족증후군의 자운고 치료 1례

A case report of Hand-foot syndrome due to sorafenib with Jaungo

  • 강용휘 (대전대학교 둔산한방병원 동서생명과학연구원) ;
  • 이가영 (대전대학교 둔산한방병원 동서생명과학연구원) ;
  • 박찬란 (대전대학교 둔산한방병원 동서생명과학연구원) ;
  • 조정효 (대전대학교 둔산한방병원 동서생명과학연구원) ;
  • 손창규 (대전대학교 둔산한방병원 동서생명과학연구원) ;
  • 이남헌 (대전대학교 둔산한방병원 동서생명과학연구원)
  • Kang, Yong-hwi (Institute of Traditional Medicine and Bioscience, Dunsan Hospital of Daejeon University) ;
  • Lee, Ga-young (Institute of Traditional Medicine and Bioscience, Dunsan Hospital of Daejeon University) ;
  • Park, Chan-Ran (Institute of Traditional Medicine and Bioscience, Dunsan Hospital of Daejeon University) ;
  • Cho, Jung-hyo (Institute of Traditional Medicine and Bioscience, Dunsan Hospital of Daejeon University) ;
  • Son, Chang-gue (Institute of Traditional Medicine and Bioscience, Dunsan Hospital of Daejeon University) ;
  • Lee, Nam-hun (Institute of Traditional Medicine and Bioscience, Dunsan Hospital of Daejeon University)
  • 투고 : 2019.08.26
  • 심사 : 2019.09.23
  • 발행 : 2019.09.21
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives : The purpose of this case study is to report the effect of Korean medicine on hand-foot syndrome(HFS) casued by sorafenib(nexavar) in hepatocellular carcinoma. Methods : The patient, 77-year-old patient complaining with pain, swelling and erythema on both hands and feet which is characterized as HFS was treated with Jaungo. We evaluated the symptoms by Numeric Rating Scale and pictures. Results : The symptoms of HFS has been alleviated during the treatment. Conclusions : We suggest Jaungo as one of the alternative therapies for HFS due to sorafenib.

키워드

참고문헌

  1. Amy SC, Linda TV. Chemotherapy-induced palmar-plantar erythrodysesthesia syndrome: etiology and emerging therapies. Support Cancer Therapy. 2004;1(4): 213-8. https://doi.org/10.3816/SCT.2004.n.013
  2. Azuma Y, Hata K, Sai K, Udagawa R, Hirakawa A, Tohkin M, et al. Significant association between hand-foot syndrome and efficacy of capecitabine in patients with metastatic breast cancer. Biological and Pharmaceutical Bulletin. 2012;35(5): 717-24. https://doi.org/10.1248/bpb.35.717
  3. Wehler TC, Cao Y, Galle PR, Theobald M, Moehler M, Schimanski CC. Combination therapies with oxaliplatin and oral capecitabine or intravenous 5-FU show similar toxicity profiles in gastrointestinal carcinoma patients if hand-food syndrome prophylaxis is performed continuously. Oncology Letters. 2012;3(6):1191-4. https://doi.org/10.3892/ol.2012.640
  4. Zhao C, Chen J, Yu B, Wu X, Dai C, Zhou C et al. Effect of modified taohongsiwu decoction on patients with chemotherapy-induced hand-foot syndrome. Journal of Traditional Chinese Medicine. 2014;34(1):10-4. https://doi.org/10.1016/S0254-6272(14)60047-9
  5. Huang L, Li B, Hu Z. Therapeutic effect of Jiawei Huangqi Guizhi Wuwu Decoction on prevention and treatment of Xeloda-related hand-foot syndrome. Journal of Research on Integrative Medicine. 2014;2(1):26-8.
  6. Ying HF, Guo YB, Zheng L, Zhang WY, Cao Q, Shen XH. Clinical Observation of Wuwei Xuanbi Decoction of Early Intervention on Colon Cancer Patients with Hand Foot Syndrome Cause by Capecitabine. Journal of Liaoning College of Traditional Chinese Medicine. 2014;16(10):108-10.
  7. Han GJ, Jang MW, Seong S, Kim SS. A Case Report of Chemotherapy-Induced Hand-Foot Syndrome Treated with Modified Dohongsamul-tang. Journal of Internal Korean Medicine. 2018;39(2):259-67. https://doi.org/10.22246/jikm.2018.39.2.259
  8. McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clinical Liver Diseases. 2015:19(2):223-38. https://doi.org/10.1016/j.cld.2015.01.001
  9. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. The New England Journal of Medicine. 2008;359(4):378-90. https://doi.org/10.1056/NEJMoa0708857
  10. Grandinetti CA, Goldspiel BR. Sorafenib and sunitinib: novel targeted therapies for renal cell cancer. Pharmacotherapy. 2007;27(8):1125-44. https://doi.org/10.1592/phco.27.8.1125
  11. Gridelli C, Maione P, Del Gaizo F, Colantuoni G, Guerriero C, Ferrara C, et al. Sorafenib and sunitinib in the treatment of advanced non-small cell lung cancer. Oncologist. 2007:12(2):191-200. https://doi.org/10.1634/theoncologist.12-2-191
  12. Robert C, Mateus C, Spatz A, Wechsler J, Escudier B. Dermatologic symptoms associated with the multikinase inhibitor sorafenib. Journal of American Academy of Dermatology. 2009;60(2):299-305. https://doi.org/10.1016/j.jaad.2008.06.034
  13. Baack BR, Burgdorf WH. Chemotherapy-induced acral erythema. Journal of American Academy of Dermatology. 1991;24(3):457-61. https://doi.org/10.1016/0190-9622(91)70073-B
  14. Lacouture ME, Wu S, Robert C, Atkins MB, Kong HH, Guitart J, et al. Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib. Oncologist. 2008;13:1001-11. https://doi.org/10.1634/theoncologist.2008-0131
  15. Kollmannsberger C, Soulieres D, Wong R, Scalera A, Gaspo R, Bjarnason G. Sunitinib therapy for metastatic renal cell carcinoma: Recommendations for management of side effects. Canadian Urological Association Journal. 2007;1:41-54.
  16. Demirkan S, Gunduz O, Devrim T. Sorafenib-asssociated hand-foot syndrome treated with topical calcipotriol. Journal of the American Academy of Dermatology Case Reports. 2017;3(4):354-7.
  17. Von Gruenigen V, Frasure H, Fusco N, DeBernardo R, Eldermire E, Eaton S, et al. A double-blind, randomized trial of pyridoxine versus placebo for the prevention of pegylated liposomal doxorubicin-related hand-foot syndrome in gynecologic oncology patients. Cancer. 2010; 116(20):4735-43. https://doi.org/10.1002/cncr.25262
  18. Lee JC, Kim GJ. Effects of Gamijaungo on the burn mice model and the study of hematologic, pathologic and molecular mechanism. Journal of Korean Medicine Ophthalmol ogy and Otolaryngol and Dermatology. 2015;28(1):53-67. https://doi.org/10.6114/jkood.2015.28.1.053
  19. Heo JW, Eom TM, Oh JM, Choi KE, Kim HT, Seol IC, et al. Three Cases of Pressure Ulcer Treated with Hwangryunhaedok-tang Pharmacopuncture and Jaungo. Journal of Internal Korean Medicine. 2015:36(3):419-26.
  20. Yeo EJ, Han JK, Kim YH. Effects of Atopy Cream-combined with Jawoongo Ointment on the Development of Atopic Dermatitis-like Skin Lesions in NC/Nga Mouse. The Journal of Korean Oriental Pediatrics. 2009;23(1):37-72.
  21. Kim TY, Kim YM. Effects of Gagam-Jawoonaek about Erythema by UV Exposure. Korean Journal of Oriental Physiology & Pathology. 2014;28(1):94-101.